Free Trial

Tilray Brands (TLRY) Competitors

C$2.44
-0.01 (-0.41%)
(As of 06/7/2024 08:54 PM ET)

TLRY vs. APHA, BHC, CRON, THCX, WEED, GUD, ACB, FIRE, EPI, and CRDL

Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Aphria (APHA), Bausch Health Companies (BHC), Cronos Group (CRON), Hydropothecary (THCX), Canopy Growth (WEED), Knight Therapeutics (GUD), Aurora Cannabis (ACB), Supreme Cannabis (FIRE), ESSA Pharma (EPI), and Cardiol Therapeutics (CRDL). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Tilray Brands vs.

Aphria (TSE:APHA) and Tilray Brands (TSE:TLRY) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, community ranking, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

Aphria has a net margin of 0.00% compared to Aphria's net margin of -47.35%. Tilray Brands' return on equity of 0.00% beat Aphria's return on equity.

Company Net Margins Return on Equity Return on Assets
AphriaN/A N/A N/A
Tilray Brands -47.35%-9.69%-1.67%

Aphria received 381 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 68.04% of users gave Aphria an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.

CompanyUnderperformOutperform
AphriaOutperform Votes
381
68.04%
Underperform Votes
179
31.96%
Tilray BrandsOutperform Votes
No Votes
Underperform Votes
7
100.00%

In the previous week, Tilray Brands had 1 more articles in the media than Aphria. MarketBeat recorded 1 mentions for Tilray Brands and 0 mentions for Aphria. Tilray Brands' average media sentiment score of 0.00 equaled Aphria'saverage media sentiment score.

Company Overall Sentiment
Aphria Neutral
Tilray Brands Neutral

Tilray Brands has a consensus target price of C$2.95, suggesting a potential upside of 20.90%. Given Aphria's higher possible upside, analysts plainly believe Tilray Brands is more favorable than Aphria.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aphria
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Tilray Brands
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Tilray Brands has higher revenue and earnings than Aphria. Aphria is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AphriaC$611.06M8.58-C$637.39M-C$2.01-8.23
Tilray BrandsC$743.25M2.71-C$351.95M-C$0.60-4.07

12.2% of Tilray Brands shares are owned by institutional investors. 1.2% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Tilray Brands beats Aphria on 8 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$2.02BC$1.22BC$4.93BC$3.93B
Dividend YieldN/A3.07%5.21%7.12%
P/E Ratio-4.07423.42160.0325.04
Price / Sales2.717,464.602,558.531,790.77
Price / Cash5.9510.0932.9772.85
Price / Book0.566.904.923.45
Net Income-C$351.95MC$148.96MC$105.26MC$257.67M
7 Day Performance-0.81%1,694.44%113.81%-0.58%
1 Month Performance-7.92%1,898.76%118.84%-0.74%
1 Year Performance14.55%2,080.11%128.54%15.32%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
APHA
Aphria
0 of 5 stars
N/AN/AN/AC$5.24BC$611.06M-8.231,200
BHC
Bausch Health Companies
0.0859 of 5 stars
C$8.63
+1.3%
C$9.00
+4.3%
-9.9%C$3.17BC$8.97B-5.1120,270
CRON
Cronos Group
0 of 5 stars
C$3.38
-1.5%
C$3.18
-5.9%
+50.9%C$1.29BC$93.03M-17.79356
THCX
Hydropothecary
0 of 5 stars
C$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
WEED
Canopy Growth
0.0421 of 5 stars
C$9.63
-1.3%
C$5.40
-43.9%
+958.2%C$722.73MC$362.24M-0.452,700Analyst Forecast
GUD
Knight Therapeutics
1.2641 of 5 stars
C$5.86
-0.2%
C$6.75
+15.2%
+17.7%C$594.09MC$332.21M-36.63725Positive News
ACB
Aurora Cannabis
0 of 5 stars
C$7.84
-4.3%
C$2.26
-71.1%
+1,020.0%C$427.59MC$275.88M-0.101,130Upcoming Earnings
FIRE
Supreme Cannabis
0 of 5 stars
N/AN/AN/AC$259.40MC$53.29M-10.97400
EPI
ESSA Pharma
0 of 5 stars
C$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725
CRDL
Cardiol Therapeutics
0 of 5 stars
C$3.32
-2.6%
N/A+245.8%C$229.08MN/A-7.06N/A

Related Companies and Tools

This page (TSE:TLRY) was last updated on 6/10/2024 by MarketBeat.com Staff

From Our Partners